Investigator Highlights
Our success comes from a team of dedicated researchers who combine science, technology, and compassion to improve the lives of people with bleeding and clotting disorders.
Dr. Beth Warren — Improving Joint Health Through Innovation
-2019web.jpg?sfvrsn=7c0a31b9_4)
Dr. Beth Warren studies how bleeding disorders affect joint health, movement, and quality of life. She leads clinical studies in our Motion Analysis Lab, where cameras and sensors track how people with bleeding disorders walk and exercise. Her research is helping create better physical therapy and exercise programs that keep patients active and protect their joints.
Dr. Chris Ng — Advancing Understanding of Von Willebrand Disease
Dr. Chris Ng investigates why people have different levels of von Willebrand factor, a key protein in blood clotting. By studying patient-derived blood vessel cells, his team has identified factors that control how this protein is made and released. His goal is to turn these findings into better diagnostic tests and personalized treatments for bleeding and clotting disorders.
Dr. Marilyn Manco-Johnson — Transforming Care for Children with Hemophilia
Dr. Marilyn Manco-Johnson directs clinical and research programs that define the best treatments for children with bleeding disorders. Her groundbreaking work showing that regular, preventive infusions of clotting factor can prevent joint damage has changed care for children with severe hemophilia around the world. She continues to lead studies on new factor therapies, global tests of clotting function, and long-term outcomes that guide the next generation of hemophilia care.
Dr. Keith Neeves — Engineering New Frontiers
Dr. Keith Neeves is an engineer who studies how blood clots form and how to treat or prevent dangerous blockages. His lab builds “blood clotting-on-a-chip” devices that let researchers watch clotting happen in real time and test new medicines safely. He also develops magnetic microbots that deliver clot-busting drugs directly to a blockage, aiming for faster and safer thrombosis treatments.